Novavax IncNASDAQ:NVAX
- LAST PRICE4.5050
- TODAY'S CHANGE (%)0.0350 (0.7830%)
- Bid / Lots4.5000/ 51
- Ask / Lots4.5100/ 19
- Open / Previous Close4.4800 / 4.4700
- Day Range
- 52 Week Range
- Volume1,290,636
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NVAX |
|---|---|---|
| 09:32 ET | 31354 | 4.53 |
| 09:34 ET | 13347 | 4.5 |
| 09:36 ET | 18473 | 4.515 |
| 09:38 ET | 23586 | 4.49 |
| 09:39 ET | 26474 | 4.46 |
| 09:41 ET | 18555 | 4.48 |
| 09:43 ET | 4808 | 4.4874 |
| 09:45 ET | 17809 | 4.52 |
| 09:48 ET | 18718 | 4.4901 |
| 09:50 ET | 9936 | 4.495 |
| 09:52 ET | 12926 | 4.5285 |
| 09:54 ET | 14511 | 4.5 |
| 09:56 ET | 3071 | 4.495 |
| 09:57 ET | 55857 | 4.47 |
| 09:59 ET | 7795 | 4.49 |
| 10:01 ET | 16072 | 4.52 |
| 10:03 ET | 10972 | 4.5 |
| 10:06 ET | 8095 | 4.49 |
| 10:08 ET | 4868 | 4.51 |
| 10:10 ET | 2156 | 4.505 |
| 10:12 ET | 30228 | 4.515 |
| 10:14 ET | 27087 | 4.525 |
| 10:15 ET | 5650 | 4.51 |
| 10:17 ET | 7240 | 4.52 |
| 10:19 ET | 29880 | 4.485 |
| 10:21 ET | 4024 | 4.485 |
| 10:24 ET | 8482 | 4.495 |
| 10:26 ET | 2585 | 4.495 |
| 10:28 ET | 4326 | 4.495 |
| 10:30 ET | 4017 | 4.5001 |
| 10:32 ET | 10841 | 4.5 |
| 10:33 ET | 1736 | 4.505 |
| 10:35 ET | 32062 | 4.49 |
| 10:37 ET | 12611 | 4.5017 |
| 10:39 ET | 2700 | 4.5014 |
| 10:42 ET | 500 | 4.505 |
| 10:44 ET | 27932 | 4.515 |
| 10:46 ET | 13994 | 4.52 |
| 10:48 ET | 17935 | 4.52 |
| 10:50 ET | 4253 | 4.5199 |
| 10:51 ET | 10375 | 4.505 |
| 10:53 ET | 61922 | 4.535 |
| 10:55 ET | 5227 | 4.5399 |
| 10:57 ET | 3218 | 4.54 |
| 11:00 ET | 9243 | 4.54 |
| 11:02 ET | 24895 | 4.545 |
| 11:04 ET | 15655 | 4.545 |
| 11:06 ET | 8082 | 4.545 |
| 11:08 ET | 3400 | 4.535 |
| 11:09 ET | 24201 | 4.525 |
| 11:11 ET | 21665 | 4.505 |
| 11:13 ET | 5558 | 4.51 |
| 11:15 ET | 24994 | 4.515 |
| 11:18 ET | 1466 | 4.52 |
| 11:20 ET | 8735 | 4.525 |
| 11:22 ET | 5130 | 4.53 |
| 11:24 ET | 7232 | 4.52 |
| 11:26 ET | 2033 | 4.52 |
| 11:27 ET | 3550 | 4.515 |
| 11:29 ET | 4450 | 4.51 |
| 11:31 ET | 6250 | 4.505 |
| 11:33 ET | 5100 | 4.505 |
| 11:36 ET | 13071 | 4.52 |
| 11:38 ET | 2700 | 4.52 |
| 11:40 ET | 1600 | 4.52 |
| 11:42 ET | 44495 | 4.505 |
| 11:44 ET | 9462 | 4.515 |
| 11:45 ET | 3566 | 4.51 |
| 11:47 ET | 1619 | 4.515 |
| 11:49 ET | 6500 | 4.515 |
| 11:51 ET | 3121 | 4.52 |
| 11:54 ET | 1421 | 4.515 |
| 11:56 ET | 12046 | 4.525 |
| 11:58 ET | 1882 | 4.5287 |
| 12:00 ET | 8628 | 4.53 |
| 12:02 ET | 9742 | 4.535 |
| 12:03 ET | 1652 | 4.52 |
| 12:05 ET | 470 | 4.525 |
| 12:07 ET | 400 | 4.525 |
| 12:09 ET | 900 | 4.52 |
| 12:12 ET | 3488 | 4.52 |
| 12:14 ET | 11333 | 4.51 |
| 12:16 ET | 8961 | 4.515 |
| 12:18 ET | 8058 | 4.525 |
| 12:20 ET | 5123 | 4.525 |
| 12:21 ET | 2479 | 4.5281 |
| 12:23 ET | 5311 | 4.525 |
| 12:25 ET | 14061 | 4.52 |
| 12:27 ET | 1494 | 4.515 |
| 12:30 ET | 6433 | 4.51 |
| 12:32 ET | 49463 | 4.5 |
| 12:34 ET | 24895 | 4.5 |
| 12:36 ET | 5140 | 4.5071 |
| 12:38 ET | 3600 | 4.505 |
| 12:39 ET | 300 | 4.505 |
| 12:41 ET | 928 | 4.505 |
| 12:43 ET | 1461 | 4.505 |
| 12:45 ET | 4936 | 4.51 |
| 12:48 ET | 1500 | 4.507 |
| 12:50 ET | 533 | 4.505 |
May 7, 2024
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement, from 12:18PM ET on Tuesday May 07, 2024 by Dow Jones
12:18PM ET on Tuesday May 07, 2024 by Dow JonesNovavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024, from 9:25AM ET on Tuesday May 07, 2024 by Dow Jones
9:25AM ET on Tuesday May 07, 2024 by Dow Jones
May 6, 2024
May 2, 2024
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement, from 12:31PM ET on Thursday May 02, 2024 by Dow Jones
12:31PM ET on Thursday May 02, 2024 by Dow Jones
Apr 25, 2024
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement, from 12:33PM ET on Thursday Apr 25, 2024 by Dow Jones
12:33PM ET on Thursday Apr 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Novavax Inc | 627.6M | -0.8x | --- |
PTC Therapeutics Inc | 2.4B | -4.0x | --- |
P3 Health Partners Inc | 235.7M | -1.1x | --- |
Inotiv Inc | 122.5M | -3.3x | --- |
Sinovac Biotech Ltd | 639.9M | -6.0x | --- |
Invitae Corp | 286.5K | 0.0x | --- |
Company Information
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.
Contact Information
- Headquarters
- 700 Quince Orchard RoadGAITHERSBURG, MD, United States 20878
- Phone
- 240-268-2000
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- James Young
- President, Chief Executive Officer, Director
- John Jacobs
- President, Chief Operating Officer
- John Trizzino
- Chief Financial Officer, Executive Vice President, Treasurer
- James Kelly
- President, Research and Development
- Filip Dubovsky
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $627.6M |
|---|---|
Revenue (TTM) | $983.7M |
Shares Outstanding | 140.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.43 |
EPS | $-5.53 |
Book Value | $-5.14 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | 0.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -57.59% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
